# Adjunctive Supplementation of Antioxidants (Vitamins E + C) Plus Omega-3 Fatty Acids

> **NCT00211562** · PHASE3 · TERMINATED · sponsor: **Augusta University** · enrollment: 20 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Olanzapine, Omega 3, Vitamin E+C

## Key facts

- **NCT ID:** NCT00211562
- **Lead sponsor:** Augusta University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-10
- **Primary completion:** 2006-01
- **Final completion:** —
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2012-10-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00211562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00211562, "Adjunctive Supplementation of Antioxidants (Vitamins E + C) Plus Omega-3 Fatty Acids". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00211562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*